Loading...

LIMN LIMINATUS PHARMA INC Disposals and divestitures 8-K Filing

LMNT

LMN

LIMINATUS PHARMA INC

(LIMN)

2026 8-K

Bylaw Amendment

Stock Offering Details

Settlement Agreement

Delisting Notice

Nasdaq Non-Compliance

Nasdaq Non-Compliance

Research Update

Investor Meetings

Non-Compliance Notification

Merger of Equals

Merger of Equals

External Links:

Liminatus Pharma, Inc. reported on February 6, 2026, a settlement to issue 4,000,000 shares in exchange for canceling 805,377 warrants and resolving a $7.5 million court judgment from September 11, 2025.

AI Assistant

LIMINATUS PHARMA INC

2026

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.